HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer
Public ClinicalTrials.gov record NCT01387932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Prospective, Randomized, Blinded, and Controlled Investigation of HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Carcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate overall survival in patients diagnosed with hepatocellular cancer (HCC) treated with HepaSphere/QuadraSphere Microspheres loaded with chemotherapeutic agent doxorubicin compared to conventional transarterial chemoembolization with particle PVA, lipiodol, and doxorubicin.
Study identification
- NCT ID
- NCT01387932
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 235 participants
Conditions and interventions
Conditions
Interventions
- HepaSphere/QuadraSphere Microspheres Device
- PVA, lipiodol, doxorubicin Procedure
Device · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2011 (Actual)
- Primary completion
- Feb 2021 (Actual)
- Completion
- Feb 2021 (Actual)
- Last update posted
- Nov 30, 2021
2011 – 2021
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35209 | — |
| Tuscon Medical Center | Tucson | Arizona | 85711 | — |
| Greater Arkansas Veterans Healthcare | Little Rock | Arkansas | 72205 | — |
| VA Greater Los Angeles Healthcare System | Los Angeles | California | 90073 | — |
| UCLA | Los Angeles | California | 90095 | — |
| Palo Alto Veterans Institute for Research | Palo Alto | California | 94304 | — |
| Stanford University | Stanford | California | 94305 | — |
| Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 35209 | — |
| Albany Medical Center | Albany | New York | 12208 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Albert Einstein Healthcare | Philadelphia | Pennsylvania | 19141 | — |
| VA Pittsburgh Healthcare System | Pittsburgh | Pennsylvania | 15261 | — |
| MUSC Medical Center (Medical University of South Carolina) | Charleston | South Carolina | 29425 | — |
| UT Health and Science Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01387932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 30, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01387932 live on ClinicalTrials.gov.